PROVECTUS BIOPHARMACEUTICA-A (PVCT:OTCMKTS)
$0.057 0.0015 (2.7027%)
Analysed PROVECTUS BIOPHARMACEUTICA-A (PVCT:OTCMKTS) News Sources
Provectus Biopharmaceuticals Highlights Preclinical Evidence of PV-10-Mediated Immune Modulation in Burn Wound Healing; Porcine Study Demonstrates Shift Toward Pro-Regenerative Tissue Environment
02-04-2026
yahoo.com
Provectus: Q4 Earnings Snapshot
26-03-2026
yahoo.com
Provectus: Q3 Earnings Snapshot
13-11-2025
yahoo.com
Provectus Biopharmaceuticals Positions PV-10 as a Differentiated Alternative to Traditional Vaccine Adjuvants; University of Calgary Research Highlights Novel STING-Pathway Activation for Improving Hepatitis B Vaccine Efficacy
09-10-2025
yahoo.com
Provectus Biopharmaceuticals Initiates Preclinical Study of Oral PV-10 in Bladder Cancer
29-09-2025
yahoo.com
Provectus: Q2 Earnings Snapshot
14-08-2025
yahoo.com
Provectus Biopharmaceuticals Announces Publication of Moffitt Cancer Center Research on PV-10 for Head and Neck Cancer
26-06-2025
yahoo.com
Provectus Biopharmaceuticals Announces Investor Webinar for 2025 Annual Meeting of Stockholders
09-06-2025
yahoo.com
Provectus: Q1 Earnings Snapshot
14-05-2025
yahoo.com
What is the current price of PROVECTUS BIOPHARMACEUTICA-A (PVCT:OTCMKTS)?
The current price of PROVECTUS BIOPHARMACEUTICA-A (PVCT:OTCMKTS) is $0.057.
PROVECTUS BIOPHARMACEUTICA-A (PVCT:OTCMKTS) absolute price change since previous trading day?
The absolute price change of PROVECTUS BIOPHARMACEUTICA-A (PVCT:OTCMKTS) since the previous trading day is $0.0015.
PROVECTUS BIOPHARMACEUTICA-A (PVCT:OTCMKTS) percentage price change since previous trading day?
The percentage price change of PROVECTUS BIOPHARMACEUTICA-A (PVCT:OTCMKTS) since the previous trading day is 2.7027%.
What is the most recent average sentiment score for PROVECTUS BIOPHARMACEUTICA-A (PVCT:OTCMKTS)?
The most recent average sentiment score for PROVECTUS BIOPHARMACEUTICA-A (PVCT:OTCMKTS) is 50 out of 100.
What is the most recent average sentiment for PROVECTUS BIOPHARMACEUTICA-A (PVCT:OTCMKTS)?
The most recent sentiment for PROVECTUS BIOPHARMACEUTICA-A (PVCT:OTCMKTS) is .
SEC-8K** Filing Available For PROVECTUS BIOPHARMACEUTICA-A (PVCT:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.